Mettler-Toledo International (NYSE:MTD) Updates FY 2026 Earnings Guidance

Mettler-Toledo International (NYSE:MTD) updated its FY 2026 earnings guidance on Thursday. The company provided EPS guidance of 46.050-46.700 for the period, compared to the consensus EPS estimate of 45.780. The company issued revenue guidance of $4.2 billion-$4.2 billion, compared to the consensus revenue estimate of $4.2 billion. Mettler-Toledo International also updated its Q1 2026 guidance to 8.600-8.750 EPS.

Analysts Set New Price Targets

Several brokerages recently issued reports on MTD. Wells Fargo & Company increased their price objective on Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the stock an “equal weight” rating in a research note on Monday, December 15th. Bank of America raised shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price objective on the stock in a research report on Monday, December 15th. Stifel Nicolaus increased their target price on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the stock a “buy” rating in a research report on Monday, November 10th. Barclays lowered their price target on shares of Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating on the stock in a report on Monday, December 15th. Finally, Citigroup increased their price objective on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a report on Monday, November 10th. Six analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat, Mettler-Toledo International presently has a consensus rating of “Hold” and a consensus target price of $1,441.67.

Mettler-Toledo International Trading Down 0.5%

Mettler-Toledo International stock traded down $6.41 during mid-day trading on Thursday, hitting $1,383.32. 174,297 shares of the company’s stock were exchanged, compared to its average volume of 128,264. Mettler-Toledo International has a 1-year low of $946.69 and a 1-year high of $1,525.17. The stock has a 50 day moving average of $1,426.00 and a two-hundred day moving average of $1,357.10. The stock has a market cap of $28.26 billion, a P/E ratio of 33.22, a P/E/G ratio of 4.13 and a beta of 1.42.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings data on Thursday, February 5th. The medical instruments supplier reported $13.36 EPS for the quarter, beating analysts’ consensus estimates of $12.76 by $0.60. Mettler-Toledo International had a negative return on equity of 426.96% and a net margin of 21.20%.During the same quarter last year, the business posted $12.41 EPS. The business’s revenue was up 8.1% on a year-over-year basis. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. As a group, research analysts predict that Mettler-Toledo International will post 42.71 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, insider La Guerroniere Marc De sold 6,055 shares of the firm’s stock in a transaction dated Tuesday, November 25th. The stock was sold at an average price of $1,488.18, for a total value of $9,010,929.90. Following the sale, the insider directly owned 187 shares of the company’s stock, valued at approximately $278,289.66. This trade represents a 97.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Gerry Keller sold 236 shares of Mettler-Toledo International stock in a transaction dated Friday, November 21st. The stock was sold at an average price of $1,418.58, for a total value of $334,784.88. Following the completion of the transaction, the insider owned 159 shares in the company, valued at $225,554.22. The trade was a 59.75% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 19,565 shares of company stock valued at $28,683,737 in the last three months. Company insiders own 1.94% of the company’s stock.

Mettler-Toledo International News Summary

Here are the key news stories impacting Mettler-Toledo International this week:

• Positive Sentiment: Q4 results beat expectations — Adjusted EPS of $13.36 topped the Zacks/consensus $12.76 and rose ~8% year-over-year, showing continued earnings strength. Read More.
• Positive Sentiment: Sales growth and operating performance — Reported sales rose 8% (5% in local currency) with adjusted EPS up; core business growth plus a small acquisition benefit were cited. Read More.
• Positive Sentiment: Full‑year FY2026 guidance modestly above consensus — Company set FY EPS guidance of $46.05–46.70 vs. street ~45.78, signaling confidence in medium‑term profitability. Read More.
• Neutral Sentiment: Valuation & analyst context — MTD trades at a high multiple (PE ~34.5) with PEG ~4.1; analysts expect ~42.7 EPS for the fiscal year, so the stock is priced for continued strong execution. Read More.
• Negative Sentiment: Near‑term guidance disappointed — Q1 FY2026 EPS guidance of $8.60–8.75 and revenue guidance (~$910.3M) came in below consensus (~$8.94 EPS and ~$934M revenue), creating concern about sequential softness and weighing on the stock. Read More.

Institutional Investors Weigh In On Mettler-Toledo International

A number of institutional investors have recently bought and sold shares of the business. Bank of America Corp DE raised its position in Mettler-Toledo International by 56.8% in the 3rd quarter. Bank of America Corp DE now owns 128,116 shares of the medical instruments supplier’s stock valued at $157,276,000 after purchasing an additional 46,402 shares during the last quarter. Arrowstreet Capital Limited Partnership raised its holdings in shares of Mettler-Toledo International by 6.0% in the third quarter. Arrowstreet Capital Limited Partnership now owns 72,365 shares of the medical instruments supplier’s stock valued at $88,836,000 after buying an additional 4,106 shares during the last quarter. Man Group plc lifted its position in Mettler-Toledo International by 72.5% during the 2nd quarter. Man Group plc now owns 62,038 shares of the medical instruments supplier’s stock worth $72,877,000 after buying an additional 26,073 shares in the last quarter. Holocene Advisors LP grew its holdings in Mettler-Toledo International by 320.2% during the 2nd quarter. Holocene Advisors LP now owns 56,439 shares of the medical instruments supplier’s stock worth $66,300,000 after acquiring an additional 43,007 shares during the last quarter. Finally, Sei Investments Co. increased its position in Mettler-Toledo International by 1.6% in the 3rd quarter. Sei Investments Co. now owns 43,087 shares of the medical instruments supplier’s stock valued at $52,899,000 after acquiring an additional 685 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.